Trials / Completed
CompletedNCT02711358
Indomethacin Use in Pain Relief During Intrauterine Device Insertion
Rectal Indomethacin Use in Pain Relief During Intrauterine Device Insertion: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the investigators study is to test the analgesic effect of rectal indomethacin during Intrauterine device insertion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | indomethacin suppositories | The patients will be instructed to self-administer a single rectal dose of 50 mg indomethacin 30 min before the scheduled time of the procedure |
| DRUG | placebo | The patient swill be instructed to self-administer a single rectal dose of placebo 30 min before the scheduled time of the procedure |
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-07-01
- Completion
- 2016-10-01
- First posted
- 2016-03-17
- Last updated
- 2016-11-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02711358. Inclusion in this directory is not an endorsement.